Aterium Atropine Sulphate Injection I.P. 0.65mg
Quality Assurance & Dispatch
Aterium Atropine Sulphate Injection I.P. 0.65mg
CC03Product Summary
Aterium-0.65 Atropine Sulphate Injection I.P. 0.65 mg/ml is a prescription anticholinergic medicine used in hospitals, ICUs, emergency departments, and critical care units. It is used in the management of symptomatic bradycardia, organophosphate poisoning, and selected pre-anaesthetic procedures. Available in 1 ml × 100 glass ampoules, suitable for IV, IM, or SC administration under qualified medical supervision. Marketed by Essentials Emporium Enterprises, India.
Aterium-0.65 Atropine Sulphate Injection I.P. 0.65 mg/ml is a prescription anticholinergic and antimuscarinic medication used in hospitals, emergency departments, intensive care units (ICUs), operation theatres and critical care facilities.
Each 1 ml ampoule contains Atropine Sulphate I.P. 0.65 mg, formulated as an injectable solution for intravenous (IV), intramuscular (IM) or subcutaneous (SC) administration, as directed by a qualified medical professional.
Atropine Sulphate works by blocking the action of acetylcholine at muscarinic receptors. It helps increase heart rate, reduce certain glandular secretions and counteract excessive muscarinic activity in specific medical emergencies.
Aterium-0.65 Injection may be used in the management of symptomatic bradycardia (abnormally slow heart rate), as a pre-anaesthetic medication in selected cases, and as part of emergency treatment for organophosphate poisoning and other cholinergic conditions, according to approved clinical protocols.
The product is available in a 1 ml × 100 ampoules pack, suitable for authorized hospital pharmacies, healthcare institutions, emergency medical departments and pharmaceutical distribution channels.
Marketed by Essentials Emporium Enterprises, Aterium-0.65 is intended for professional medical and institutional pharmaceutical supply.
Key Features
Composition
Each ml contains:
Atropine Sulphate I.P. ............... 0.65 mg
Water for Injection I.P. ............ q.s.
Indications and Uses
Symptomatic Bradycardia
Used in selected cases of clinically significant slow heart rate, according to established emergency treatment guidelines.
Pre-Anaesthetic Medication
May be administered before certain surgical or anaesthetic procedures to reduce salivary and respiratory secretions.
Organophosphate Poisoning
Used as an antidote to counteract muscarinic effects associated with organophosphate pesticide poisoning.
Cholinergic Emergencies
May be used to manage excessive muscarinic activity caused by certain toxic exposures or medications.
Perioperative Care
May be used to manage certain vagally mediated cardiovascular responses during surgical or anaesthetic procedures.
Dosage and Administration
As directed by the physician.
The appropriate dose and route of administration depend on the patient's clinical condition, age, medical history and applicable treatment protocol.
For administration by qualified healthcare professionals only.
Storage Instructions
Packaging Details
Suitable For
Manufactured By
PREVEGO HEALTHCARE & RESEARCH PRIVATE LIMITED
28, Whispering Plams Bldg No. 5 CHS Ltd, Akurli Road, Opp. Mahindra Gate No. 2, Kandivali (E), Mumbai, Maharashtra, India – 400101.
Marketed By
Essentials Emporium Enterprises
15/7, Ground Floor, DDA Complex, RBC Nangal Raya, Delhi – 110046, India